Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Stem Cells Translational Medicine|April 27, 2026
Moderate neuroprotection of combination cell therapy in fetal growth restricted newborns at postnatal day 10Kirat K Chand, Kate Beecher, Rachel Nano, et al.
Cancer Discovery|July 31, 2014
Dual inhibition of EGFR with afatinib and cetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutationsYelena Y Janjigian, Egbert F Smit, Harry J M Groen, et al.
Cancer|June 19, 2013
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activationEunice L Kwak, Geoffrey I Shapiro, Seth M Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2020
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC StudyHan Si, Michael Kuziora, Katie J Quinn, et al.
Blood|December 4, 2023
CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in miceRachael C Adams, Dylan Carter-Cusack, Genesis T Llanes, et al.
The Lancet. Oncology|July 10, 2015
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trialJean-Charles Soria, Enriqueta Felip, Manuel Cobo, et al.
Frontiers in Immunology|June 14, 2019
Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular DysfunctionsDechao Cao, Juan Zhao, Lam N Nguyan, et al.
The Indian Journal of Medical Research|May 8, 2012
Retrospective study of chikungunya outbreak in urban areas of IndiaB N Nagpal, Rekha Saxena, Aruna Srivastava, et al.
Global Mental Health (Cambridge, England)|September 13, 2021
Cross cultural and global uses of a digital mental health app: results of focus groups with clinicians, patients and family members in India and the United StatesElena Rodriguez-Villa, Abhijit R Rozatkar, Mohit Kumar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2015
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trialM Schuler, J C-H Yang, K Park, et al.
Pageof 14